Figure 1.
(A) Relapse Incidence, Non-Relapse Mortality, and (B) Overall Survival of older AML patients (>60 years) with NPM1 mutation and absence of FLT3-ITD receiving NMA-HSCT in first complete remission (n = 19).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.